Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guanxin Qiwei dropping pill
- Development stage
- Phase 4
- Lead developer
- Kelun Pharmaceutical
- Administration
- Oral
01
Overview
Guanxin Qiwei dropping pill (GXQW) is a traditional Chinese medicine (TCM) formulation composed of seven medicinal botanical ingredients, including Myristicae semen, Choerospondiatis fructus, Santali albi lignum, Codonopisis radix, Kaempferiae Rhizoma, and Dalbergiae odoriferae lignum. Developed and manufactured by Sichuan Kelun Pharmaceutical and its subsidiary Liaoning Minkang Pharmaceutical, it is primarily indicated for the treatment of stable angina pectoris due to coronary heart disease, particularly in patients presenting with TCM blood stasis syndrome. GXQW exerts its therapeutic effects by promoting blood circulation, resolving blood stasis, and alleviating pain. Preclinical studies suggest it may also improve atherosclerosis by modulating gut microbiota (such as reducing the abundance of *Dubosiella*) and regulating lipid metabolism and inflammatory pathways.
- Brand names
- Guanqi
- Other names
- Guanxin Qiwei dropping pillsGuanxin Qiwei DiwanGXQW
02
Targets
ACE (Angiotensin Converting Enzyme)ESR2 (ERβ)PPARG (Peroxisome proliferator-activated receptor gamma)VEGFR2 (Vascular endothelial growth factor receptor 2)
Beyond the preview
Go deeper on Guanxin Qiwei dropping pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guanxin Qiwei dropping pill.